Synthesis 2021; 53(20): 3799-3814
DOI: 10.1055/a-1523-1409
paper

Aminothiaindanone as an Accessible Scaffold for a Three-Point Chemical Diversity

Pauline Zipfel
,
Julien Lalut
,
Jana Sopková-de Oliveira Santos
,
Christophe Rochais
,
This program was co-funded by the European Union within the framework of the Operational Programm ERDF/ESF 2014–2020 and by the Regional Council of Normandy (RIN ChemImaging).


Abstract

Aminothiaindanone heterocycle appears to be a scaffold of interest in medicinal chemistry. To increase the chemical diversity in this series, the introduction of three-point chemical diversity on the cyclopenta[b]thiophen-4-one scaffold was explored. About thirty newly functionalized thiophene-containing bicycles were obtained using various chemical reactions, paving the way for novel possibilities in medicinal chemistry projects.

Supporting Information



Publication History

Received: 26 April 2021

Accepted after revision: 04 June 2021

Accepted Manuscript online:
04 June 2021

Article published online:
13 July 2021

© 2021. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Taylor AP, Robinson RP, Fobian YM, Blakemore DC, Jones LH, Fadeyi O. Org. Biomol. Chem. 2016; 14: 6611
  • 2 Jampilek J. Molecules 2019; 24: 3839
  • 3 Pathania S, Narang RK, Rawal RK. Eur. J. Med. Chem. 2019; 180: 486
  • 4 Singh A, Singh G, Bedi PM. S. J. Heterocycl. Chem. 2020; 57: 2658
  • 5 Alsaidi A, al Shargapi S, Dallemagne P, Carreiras F, Gauduchon P, Rault S, Robba M. Chem. Pharm. Bull. 1994; 42: 1605
  • 6 Khanh LP, Dallemagne P, Landelle H, Rault S. J. Enzyme Inhib. Med. Chem. 2002; 17: 439
  • 7 Dallemagne P, Khanh LP, Alsadi A, Renault O, Varlet I, Collot V, Bureau R, Rault S. Bioorg. Med. Chem. 2002; 10: 2185
  • 8 Dallemagne P, Khanh LP, Alsaïdi A, Varlet I, Collot V, Paillet M, Bureau R, Rault S. Bioorg. Med. Chem. 2003; 11: 1161
    • 9a Matthias L, Buchstaller H.-P. Patent WO 2019/219731 A1, 2019
    • 9b Abdel-Magid AF. ACS Med. Chem. Lett. 2020; 11: 1083
  • 10 Omran Z, Cailly T, Lescot E, Sopkova-De Oliveira-Santos J, Agondanou J.-H, Lisowski V, Fabis F, Godard A.-M, Stiebing S, Le Flem G, Boulouard M, Dauphin F, Dallemagne P, Rault S. Eur. J. Med. Chem. 2005; 40: 1222
  • 11 Omran Z, Stiebing S, Godard A.-M, Sopkova-De Oliveira Santos J, Dallemagne P. J. Enzyme Inhib. Med. Chem. 2008; 23: 696
  • 12 Genest D, Rochais C, Lecoutey C, Sopkova-De Oliveira San os JS, Ballandonne C, Butt-Gueulle S, Legay R, Since M, Dallemagne P. Med. Chem. Commun. 2013; 4: 925
  • 13 Chermann J.-C, Dallemagne P, Pilo Vicente J.-C, Rault S, Robba M. Patent FR2682383B1, 1991
  • 14 Dezi C, Brea J, Alvarado M, Raviña E, Masaguer CF, Loza MI, Sanz F, Pastor M. J. Med. Chem. 2007; 50: 3242
  • 15 Guillon J, Hébert G, Dallemagne P, Léger JM, Vidaillac C, Thé C, Lisowski V, Rault S, Demotes-Mainard J, Jarry C. J. Enzyme Inhib. Med. Chem. 2003; 18: 147
  • 16 Pinna G, Curzu MM, Dore A, Lazzari P, Ruiu S, Pau A, Murineddu G, Pinna GA. Eur. J. Med. Chem. 2014; 85: 747
  • 17 Quermonne M, Dallemagne P, Louchahi-Raoul J, Pilo J, Rault S, Robba M. Eur. J. Med. Chem. 1992; 27: 961
  • 18 Dallemagne P, Rault S, Robba M. Bull. Soc. Chim. Fr. 1991; 128: 260
  • 19 Khanh LP, Dallemagne P, Rault S. Synlett 1999; 1450
  • 20 Podlesný J, Pytela O, Klikar M, Jelínková V, Kityk IV, Ozga K, Jedryka J, Rudysh M, Bureš F. Org. Biomol. Chem. 2019; 17: 3623
  • 21 Yang W, Luo Z, Sun R, Guo J, Wang T, Wu Y, Wang W, Guo J, Wu Q, Shi M, Li H, Yang C, Min J. Nat. Commun. 2020; 11: 1218
  • 22 Novotná E, Kityk IV, Pytela O, Bureš F, Ludwig M, Klikar M, Ozga K, Jedryka J. ChemPlusChem 2020; 85: 1549
  • 23 Dallemagne P, Rault S, de Sévricourt HC, Hassan KM, Robba M. Tetrahedron Lett. 1986; 27: 2607
  • 24 Dallemagne P, Rault S, Gordaliza M, Robba M. Heterocycles 1987; 26: 3233
  • 25 Dallemagne P, Alsaidi A, Boulouard M, Rault S, Robba M. Heterocycles 1993; 36: 287
  • 26 Garrison Kinney R, Tjutrins J, Torres GM, Liu NJ, Kulkarni O, Arndtsen BA. Nat. Chem. 2018; 10: 193
  • 27 Song L, Tian G, Van der Eycken EV. Chem. Eur. J. 2019; 25: 7645
  • 28 Wu Y, Zhang T, Hao W, Tu S, Jiang B. Asian J. Org. Chem. 2020; 9: 1040
  • 29 Hanchate V, Devarajappa R, Prabhu KR. Org. Lett. 2020; 22: 2878
  • 30 Wu B, Yang J, Gao M, Hu L. Org. Lett. 2020; 22: 5561
  • 31 Fan L.-F, Wang T.-C, Wang P.-S, Gong L.-Z. Organometallics 2019; 38: 4014
  • 32 Nitti A, Bianchi G, Po R, Swager TM, Pasini D. J. Am. Chem. Soc. 2017; 139: 8788
  • 33 Nitti A, Osw P, Abdullah M, Galbiati A, Pasini D. Synlett 2018; 29: 2577
  • 34 Nitti A, Bianchi G, Po R, Pasini D. Synthesis 2019; 51: 677
  • 35 Nitti A, Osw P, Calcagno G, Botta C, Etkind SI, Bianchi G, Po R, Swager TM, Pasini D. Org. Lett. 2020; 22: 3263
  • 36 Fick RJ, Kroner GM, Nepal B, Magnani R, Horowitz S, Houtz RL, Scheiner S, Trievel RC. ACS Chem. Biol. 2016; 11: 748
  • 37 Renault O, Dallemagne P, Sylvain R. Org. Prep. Proced. Int. 1997; 29: 488
  • 38 Renault O, Dallemagne P, Rault S. Pharm. Pharmacol. Commun. 1998; 4: 3
  • 39 Sheldrick GM. Acta Crystallogr., Sect. A 1990; 46: 467
  • 40 Sheldrick GM. Acta Crystallogr., Sect. A 2008; 64: 112
  • 41 Kashif M, Chacón-Vargas KF, López-Cedillo JC, Nogueda-Torres B, Paz-González AD, Ramírez-Moreno E, Agusti R, Uhrig ML, Reyes-Arellano A, Peralta-Cruz J, Ashfaq M, Rivera G. Eur. J. Med. Chem. 2018; 156: 252